Clinical Trial Update: A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This document reports a phase 2 clinical trial evaluating PCS6422 in combination with capecitabine for advanced or metastatic breast cancer, currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• PCS6422 (eniluracil)

Snippet

Sponsor: Processa Pharmaceuticals | Conditions: Breast Cancer, TNBC - Triple-Negative Breast Cancer | Phase 2 | Status: RECRUITING